Transcatheter Valve Repair System Market Overview 2025-2031: Estimated Market Size, Major Drivers And Lucrative Segments - By Transparency Market Research

The global transcatheter valve repair system market, valued at USD 4.7 billion in 2022, is projected to expand at a CAGR of 7.7%, reaching USD 9.1 billion by 2031. Increasing prevalence of heart valve diseases, rising preference for minimally invasive cardiac procedures, and technological advancements in transcatheter valve repair systems are key factors driving market growth.

Explore core findings and critical insights from our Report in this sample -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85415

Market Overview

Transcatheter valve repair systems are used to treat heart valve diseases such as aortic stenosis, mitral regurgitation, and tricuspid regurgitation without requiring open-heart surgery. These minimally invasive procedures provide shorter hospital stays, faster recovery times, and reduced surgical risks, making them a preferred alternative to traditional valve repair surgeries.

Analysts' Viewpoint

The transcatheter valve repair system market is expected to witness strong growth due to:

Rise in aging population leading to increased prevalence of heart valve disorders

Growing demand for catheter-based minimally invasive valve repair procedures

Advancements in transcatheter technology improving procedural success rates

Favorable reimbursement policies boosting patient accessibility to TAVR and TMVR procedures

However, high procedural costs, shortage of skilled cardiologists, and strict regulatory approvals could restrain market growth in some regions.

Market Drivers

Increasing Prevalence of Heart Valve Diseases

Heart valve diseases (HVDs) affect over 5 million people in the U.S. alone, with aortic stenosis being the most common condition.

Aging populations and rising incidences of lifestyle-related cardiovascular conditions are fueling demand for advanced heart valve repair technologies.

According to the WHO, cardiovascular diseases remain the leading cause of death worldwide, highlighting the urgent need for improved valve repair solutions.

Shift Toward Minimally Invasive Valve Repair Procedures

TAVR and TMVR procedures have gained widespread acceptance due to shorter recovery times, lower mortality rates, and fewer complications compared to open-heart surgery.

According to the Society of Thoracic Surgeons, TAVR procedures have increased from 15,000 in 2012 to over 200,000 in 2020.

Growing adoption of minimally invasive heart treatments in developing economies is further fueling market expansion.

Continuous Advancements in Transcatheter Valve Technologies

Introduction of self-expanding and balloon-expandable transcatheter valves with improved hemodynamic performance is driving procedural success rates.

Next-generation valve designs offer reduced paravalvular leaks and better durability, making them ideal for long-term implantation.

Medtronic's latest Evolut FX TAVR system, launched in 2022, improves valve positioning accuracy and patient outcomes.

Favorable Reimbursement Policies for TAVR & TMVR Procedures

Increased insurance coverage for transcatheter valve repair procedures across North America and Europe is boosting patient access.

The U.S. Medicare program has expanded TAVR coverage for intermediate-risk patients, further driving demand.

Explore our in-depth report to gain valuable insights and takeaways -

https://www.transparencymarketresearch.com/transcatheter-valve-repair-system-market.html

Market Segmentation

By Product Type

Transcatheter Aortic Valve Replacement (TAVR) (Largest Segment), Transcatheter Mitral Valve Replacement (TMVR), Transcatheter Pulmonary Valve Replacement (TPVR), Transcatheter Tricuspid Valve Replacement (TTVR)

By Application

Aortic Stenosis, Mitral Stenosis, Tricuspid Stenosis, Pulmonary Stenosis

By End-user

Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others

Regional Outlook

North America (Dominant Market, Holding 40% Market Share in 2022)

The U.S. leads in transcatheter valve repair adoption, driven by strong healthcare infrastructure, high cardiovascular disease prevalence, and presence of key market players.

Favorable FDA approvals and Medicare reimbursement policies are boosting procedural adoption.

Abbott, Medtronic, and Edwards Lifesciences dominate the North American market.

Europe (Strong Market Growth Due to Expanding Cardiac Care Infrastructure)

Germany, France, and the U.K. lead in TAVR and TMVR adoption, supported by favorable government policies.

The European Society of Cardiology (ESC) has recommended TAVR as the preferred treatment for elderly aortic stenosis patients.

Asia Pacific (Fastest-growing Market, Expected to Expand at 9% CAGR Through 2031)

Rapid growth in cardiovascular disease cases in China, India, and Japan is increasing demand for transcatheter procedures.

Governments in India and China are investing in cardiovascular treatment infrastructure to improve access to advanced heart valve repair solutions.

Latin America & Middle East & Africa (Emerging Markets with Growth Potential)

Increasing awareness of minimally invasive cardiac procedures is driving adoption in Brazil, Mexico, and GCC countries.

Market growth is limited by high procedural costs and lack of skilled interventional cardiologists.

Competitive Landscape

The transcatheter valve repair system market is highly competitive, with key players focusing on technological advancements, product approvals, and strategic partnerships to expand their market presence.

Leading Companies:

Abbott Laboratories

Medtronic plc

Edwards Lifesciences Corporation

LivaNova Plc

Neovasc Inc.

Biotronik Pvt. Ltd.

Colibri Heart Valve

HLT Medical

Coramaze Technologies

Recent Developments:

December 2022: Abbott launched Navitor, its latest-generation TAVI system for severe aortic stenosis treatment in India.

September 2022: Medtronic announced the expanded release of Evolut FX TAVR in the U.S., improving valve placement accuracy and procedural outcomes.

2021: Edwards Lifesciences received FDA approval for the PASCAL Precision Transcatheter Valve Repair System, enhancing mitral and tricuspid valve repair procedures.

Future Outlook

The transcatheter valve repair system market is poised for sustained growth, driven by:

Rising global prevalence of heart valve diseases.

Technological advancements in TAVR, TMVR, and next-generation valve repair devices.

Increasing acceptance of minimally invasive heart valve repair techniques.

Expanding healthcare access in emerging markets.

While cost constraints and limited skilled professionals in some regions pose challenges, continuous innovations and favorable healthcare policies will ensure steady market expansion. 🚀

Buy this Premium Research Report and gain expert perspectives and analysis -

https://www.transparencymarketresearch.com/checkout.php?rep_id=85415<ype=S

FAQs

Q1: What is the growth rate of the transcatheter valve repair system market?

A: The market is expected to grow at a CAGR of 7.7% from 2023 to 2031.

Q2: Which region dominates the market?

A: North America leads the market with a 40% share, followed by Europe and Asia Pacific.

Q3: What are the key factors driving market growth?

A: Increasing heart valve disease cases, rising adoption of minimally invasive valve repair procedures, and advancements in transcatheter valve technologies.

Q4: Which companies are leading the market?

A: Abbott, Medtronic, Edwards Lifesciences, LivaNova, and Neovasc are the major players.

Increasing demand for minimally invasive heart valve treatments, technological innovations, and expanding healthcare access are key factors driving market growth

Explore Latest Research Reports by Transparency Market Research:

Cellulite Treatment Market - https://www.transparencymarketresearch.com/cellulite-treatment-market.html

Implantable Cardiac Monitor Market - https://www.transparencymarketresearch.com/implantable-cardiac-monitors-market.html

Surgery Tables Market - https://www.transparencymarketresearch.com/surgery-tables-market.html

Microdermabrasion Devices Market - https://www.transparencymarketresearch.com/microdermabrasion-devices-market.html

Anal Irrigation Systems Market - https://www.transparencymarketresearch.com/anal-irrigation-systems-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.